Paper funded by the Myrovlytis Trust published

Nahorski et al. (2011) report that codons 100-230 of FLCN are under very strong purifying selection, and that eight out of 10 missense mutations found in BHD patients disrupt the protein’s stability.

This work was funded by the Myrovlytis Trust, through a grant awarded to Professor Eamonn Maher at the University of Birmingham, UK.